CNR Institutional Research Information System

PIZZINI, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.821
NA - Nord America 1.000
EU - Europa 521
SA - Sud America 399
AF - Africa 44
OC - Oceania 6
Totale 3.791
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 918
SG - Singapore 833
CN - Cina 366
BR - Brasile 325
HK - Hong Kong 195
IT - Italia 195
VN - Vietnam 187
FR - Francia 127
BD - Bangladesh 51
KR - Corea 47
CA - Canada 40
IN - India 36
GB - Regno Unito 33
DE - Germania 29
NL - Olanda 29
AR - Argentina 23
FI - Finlandia 23
JP - Giappone 18
ID - Indonesia 15
EC - Ecuador 14
RU - Federazione Russa 12
PE - Perù 11
IE - Irlanda 10
PL - Polonia 10
ZA - Sudafrica 9
ES - Italia 8
JM - Giamaica 8
MX - Messico 8
VE - Venezuela 8
IQ - Iraq 7
MA - Marocco 7
PH - Filippine 7
SA - Arabia Saudita 7
TR - Turchia 7
AT - Austria 6
IL - Israele 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
CR - Costa Rica 5
EG - Egitto 5
HN - Honduras 5
HR - Croazia 5
PK - Pakistan 5
SE - Svezia 5
UA - Ucraina 5
AU - Australia 4
KE - Kenya 4
MY - Malesia 4
NP - Nepal 4
TT - Trinidad e Tobago 4
AL - Albania 3
AO - Angola 3
BB - Barbados 3
BE - Belgio 3
ET - Etiopia 3
NI - Nicaragua 3
PY - Paraguay 3
TN - Tunisia 3
BG - Bulgaria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CL - Cile 2
DZ - Algeria 2
GR - Grecia 2
GT - Guatemala 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
AZ - Azerbaigian 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
PW - Palau 1
RS - Serbia 1
RW - Ruanda 1
Totale 3.787
Salva come PNG Salva come JPEG
Città #
Singapore 528
Santa Clara 274
Hong Kong 194
Hefei 105
Lauterbourg 104
San Jose 88
Ashburn 77
Ho Chi Minh City 74
Beijing 67
Los Angeles 47
Seoul 47
Hanoi 45
New York 32
Dallas 28
São Paulo 25
Buffalo 15
Frankfurt am Main 14
Milan 14
Toronto 11
Helsinki 10
Rio de Janeiro 10
Tokyo 10
Curitiba 9
Dublin 9
Rome 9
Düsseldorf 8
Warsaw 8
Amsterdam 7
Biên Hòa 7
Da Nang 7
Lappeenranta 7
Montreal 7
Orem 7
Baghdad 6
Belo Horizonte 6
Brooklyn 6
Haiphong 6
Lima 6
Turku 6
Atlanta 5
Bengaluru 5
Boston 5
Catania 5
Chennai 5
Council Bluffs 5
Guayaquil 5
Louisville 5
Minamishinagawa 5
Naples 5
Quito 5
Zagreb 5
Bari 4
Belém 4
Brasília 4
Dhaka 4
Ha Long 4
Jakarta 4
Johannesburg 4
Kingston 4
London 4
McAllen 4
Miami 4
Mumbai 4
New Delhi 4
Paris 4
Paternò 4
Phoenix 4
Salvador 4
San José 4
Sheffield 4
Stockholm 4
The Bronx 4
Vienna 4
Washington 4
Addis Ababa 3
Bologna 3
Bridgetown 3
Cairo 3
Cape Town 3
Chicago 3
City of London 3
Cleveland 3
Denver 3
Florence 3
Formosa 3
Honolulu 3
Houston 3
Hải Dương 3
Joinville 3
Juiz de Fora 3
Kathmandu 3
Krasnodar 3
Las Vegas 3
Magé 3
Manila 3
Montevideo 3
Munich 3
Nairobi 3
Newark 3
Ninh Bình 3
Totale 2.170
Salva come PNG Salva come JPEG
Nome #
8-hydroxy-2′-deoxyguanosine, a biomarker of oxidative DNA injury, in diabetic kidney disease 123
Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy 122
Socioeconomic Status and Clinical Outcomes in Chronic Kidney Disease: Bootstrap Validation of a Simple Indicator 87
Osteopontin, death and cardiovascular events in stage G3–4 CKD patients: a joint model analysis 82
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patients 77
Il peptide natriuretico (BNP) è un biomarcatore della congestione polmonare nei pazienti in dialisi. 76
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 72
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients 68
Osteopontin and Clinical Outcomes in Hemodialysis Patients 68
Asymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension 63
Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patients 63
Inflammation biomarkers and inflammatory genes expression in metabolically healthy obese patients 62
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass 62
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 60
Perioperative Marinobufagenin (MBG) Measurement May Improve Acute Kidney Injury Risk Assessment in Patients Undergoing Major Cardiac Surgery: A Proof-of-Concept Study 59
CKD-MBD biomarkers and CKD progression: an analysis by the joint model 55
Salt intake correlates with night systolic blood pressure in non-dialytic chronic kidney disease 53
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 52
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 51
Quality of life and kidney function in CKD patients: a longitudinal study 51
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 51
Intact FGF23 and ?-klotho during acute inflammation/sepsis in CKD patients 49
FGF23 and the PTH response to paricalcitol in chronic kidney disease 48
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 47
Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial 44
Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients 44
Resistin and all-cause and cardiovascular mortality: Effect modification by adiponectin in end-stage kidney disease patients 43
Neuropeptide Y and chronic kidney disease progression: a cohort study 43
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients 42
Procalcitonin and the inflammatory response to salt in essential hypertension: A randomized cross-over clinical trial 41
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 40
Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial 40
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients. 39
Intact FGF23 and -klotho during acute inflammation/sepsis in CKD patients 39
Long term predictors of cerebrovascular events in patients with end stage renal disease (ESRD). 38
INDICES OF INSULIN RESISTANCE AND RISK OF TOTAL AND CARDIOVASCULAR MORTALITY IN DIALYSIS PATIENTS 37
L'obesità addominale interagisce con due citochine prodotte dal tessuto adiposo, Leptina ed Adiponectina, per predire il rischio di mortalità totale e cardiovascolare nei pazienti in dialisi. 37
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD) 37
Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients 37
I polimorfismi del gene ENPP1 si associano ad ipertrofia ventricolare sinistra ed alla funzione sistolica nei pazienti in dialisi. 37
Vitamin D and methylarginines in chronic kidney disease (CKD) 37
Il rischio di progressione delle nefropatie croniche e mortalità: ruolo dell'Asymmetrical Di-Methil-Arginine (ADMA). 33
C-Reactive Protein and Interleukin-6 modify the risk of high levels of Asymmetric Dimethyl-Arginine (ADMA) for death and cardiovascular events in end stage renal diseases patients. 33
Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study. 32
Smoking and hyperparathyroidism in patients with end-stage renal disease (ESRD). 32
Leptin and biochemical markers of bone turnover in dialysis patients 31
Association between resistin levels and all-cause and cardiovascular mortality: A new study and a systematic review and meta-analysis 31
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in ckd patients. 30
FGF23 beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease patients. 30
Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels 30
Vitamin D receptor activation by paricalcitol and insulin resistance in CKD 30
Paricalcitol and Endothelial Function in Chronic Kidney Disease Trial 29
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease 29
Urotensin II and cardiomyopathy in end-stage renal disease. 28
Urotensin II is inversely related to markers of endothelial activation and inflammation and is an inverse predictor of incident cardiovascolar events in end stage renal disease (ESRD). 28
Low triiodothyronine and survival in end-stage renal disease. 28
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 28
Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients. 27
Low triiodothyronine and survival in end stage renal disease (ESRD). 27
Pattern evolutivo dei biomarcatori di infiammazione e dei fattori di rischio non tradizionali dopo trapianto renale. 26
Vascular endothelial growth factor (VRGF) is a marker of left ventricular dysfunction and predicts mortality in hemodialysis (HD) patients. 26
Vitamin D levels and patient outcome in chronic kidney disease. 25
L'iperparatiroidismo e il TNF-a come determinanti dell'incidenza di fratture nei pazienti in dialisi: uno studio di coorte. 25
Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease 25
Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients 25
Waist circumference modifies the relationship of adipose tissue cytochines leptin and adiponectin with all-cause and cardiovascular mortality in end stage renal disease (ESRD). 25
Urotensin II and biomarkers of endothelial activation and atherosclerosis in end stage renal disease (ESRD). 25
L'infiammazione amplifica il rischio di mortalità ed eventi cardiovascolari connesso ai livelli circolanti di dimetilarginina asimmetrica (ADMA) nei pazienti in dialisi. 25
Low Triiodothyronine and Cardiomyopathy in Patients with End-Stage Renal Disease (ESRD). 24
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 24
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 24
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. 24
Asymmetric Dimethylarginine (ADMA) Enzymatic Machinery and Adipokines Gene Expression in the Adipose Tissue in Stage 3-5 CKD patients. 24
Urotensin II partecipates in cardiovascular control in end stage renal disease (ESRD). 23
Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcome stage renal disease patients. 23
Vascular Endothelial Growth Factor, rimodellamento ventricolare sinistro e disfunzione sistolica nei pazienti in dialisi 23
Beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease (CKD) patients. 23
Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease. 23
Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides 22
Methylarginine enzymatic machinery and Leptin in adipose tissue in CKD patients. 22
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in CKD patients. 22
L'ipotiroidismo subclinico si associa alla micro-infiammazione cronica e predice la mortalità nei pazienti in CAPD. Risultati di uno studio pilota di coorte. 22
Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease 20
Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients. 20
Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study 20
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. 20
Valore diagnostico per il basso turnover osseo del PTH dosato con metodi RIA di prima e seconda generazione. 20
Low triiodothyronine: a new facet of inflammation in end-stage renal disease. 20
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease. 19
Methylarginine enzymatic machinery and Leptin in adipose tissue in CKD patients. 19
Smoking and hyperparathyroidism in patients with end stage renal disease (ESRD). 19
I predittori degli eventi cardiovascolari nei pazienti in dialisi. 19
Which is the best inflammation marker? A comparative study based on multivariate modelling of mortality in end stage renal disease (ESRD) patients. 18
Intact FGF23 and -klotho during acute inflammation/sepsis in CKD patients 18
Urotensina II e fattori di rischio cardiovascolare nei pazienti con insufficienza renale cronica in trattamento dialitico. 18
BRAIN NATRIURETIC PEPTIDE AS A BIOMARKER OF PULMONARY CONGESTION IN STAGE 5 CKD ON DIALYSIS 18
Livelli circolanti di tiiodrotironina (fT3) e mortalità nei pazienti in dialisi. 18
Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections 18
Thyroid sick syndrome e miocardiopatia nei pazienti con insufficienza renale cronica. 17
Diagnostic value for low bone turnover of first and second generation immuno-radiometric PTH assay. 17
Totale 3.700
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.170
article - articoli 9.425
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202439 0 0 0 0 0 0 0 0 32 0 7 0
2024/20251.487 6 12 115 91 307 27 33 103 44 58 376 315
2025/20262.226 96 199 226 313 412 87 346 159 95 138 102 53
2026/2027141 141 0 0 0 0 0 0 0 0 0 0 0
Totale 3.893